VAX-D Questions and Answers

A "slipped" disc is an incorrect term often used to describe a bulging or herniated disc. VAX-D succeeds at treating bulging or herniated discs over 70% of the time.

VAX-D therapy is the original patented, Non-Surgical Treatment for Low Back Pain and the only treatment that delivers VAX-D's patented decompression curve, resulting in a success rate of over 70%.

VAX-D therapy has been proven to be safe and effective in numerous clinical studies. Other so-called decompression treatments' simply do not have published clinical studies proving that they can lower intradiscal pressure. VAX-D therapy is non-invasive and does not have the risks and complications associated with surgery, injections and anesthesia. VAX-D is painless and patients can continue to work and do most activities.

VAX-D is a relatively new medical procedure in the United States. The therapy has worked on thousands of patients. Over 3000 patients per day, worldwide, are now being treated. Awareness of VAX-D is spreading as physicians and healthcare providers learn about VAX-Dand the phenomenal results it has achieved in clinical studies.

VAX-D is the original decompression table upon which all others are based. Traction devices are designed to stretch the lower back. However, they have not demonstrated the ability to decompress the lumbar discs and spinal nerves. Inversion tables or traction are not able to produce a 'vacuum' effect in the disc because the muscles that surround the joints are very strong and when an attempt to stretch the joint is sensed the muscle contracts. Studies on traction show that the disc pressures often go up rather than down. The reason that the VAX-D is so effective is that the pull curve is gradual and logarithmic which "fools" the muscles and allows separation to occur. This curve is patented so no other manufacturer can use it on their tables.

There are a few individuals who can not take advantage of this treatment. The following conditions are not able to be treated on the VAX-D:

• Tumors
• Unhealed Fractures
• Advanced Osteoporosis
• Ankylosing Spondylitis
• Pregnancy
• Conditions or diseases that compromise the structural integrity of the spine and discs.

Yes. Clinical studies show that VAX-D provides relief to patients who have had one or more back surgeries. There are two exceptions to this including fixed surgical hardware used to fuse the spine and surgery that has causes spinal instability.

The VAX-D Medical Device and the procedure were developed by Allen Dyer, PhD, M.D. Dr. Dyer was a former Deputy Minister of Health in Ontario. Dr. Dyer is licensed by the College of Physicians and Surgeons National Board of Examiners USA, and the College of Pharmacy. Dr. Dyer also pioneered and published the research leading to the development of the transthoracic heart defibrillator.

Dr. Dyer himself suffered from a herniated disc. After conventional therapies failed, he formulated the theories that lead to the design and development of VAX-D therapy. After spending more than 6 years researching and developing the treatment, he introduced VAX-D in 1991. Today there are over 140 VAX-D tables in use through the United States, Puerto Rico, Canada and Australia.

Experience has shown that the majority of patients that recover on VAX-D therapy generally remain in remission and do not require additional treatment. However, some patients who have lifestyles or work environments that are higher risk have found that a maintenance program offers a measure of protection against disabling exacerbations of their low back condition. In addition, patients with degenerative conditions may find that maintenance slows the progress of the degenerative process and protects them from future exacerbations. Patients in this category tend to develop their own rhythm of maintenance visits that keeps them pain free. Most often this is one treatment per month or one treatment every other month.